SOL S.p.A. is an Italy-based company specializing in the research, production, and distribution of industrial, pure, medicinal, and technical gases, including oxygen, nitrogen, hydrogen, argon, carbon dioxide, helium, and specialized mixtures. Founded in 1927 by Giovanni Annoni and Aldo Fumagalli in Monza, it has grown into a leader in the gases sector, offering custom solutions, technologies, and equipment for industrial applications, scientific research, medicine, and food processing. The company operates through the SOL Group, with key divisions in Technical Gases and Home Care, where it provides essential services such as oxygen therapy, mechanical ventilation, sleep apnea treatment, artificial nutrition, telemedicine, and wound care management via subsidiaries like Vivisol Srl. Employing around 6,785 people, SOL S.p.A. generates significant revenue from Italy and international markets, with exports comprising over 60% of sales. Listed on the Milan stock exchange, it maintains a strong family-controlled ownership structure led by the Fumagalli family and features a seasoned executive team, including CEOs Marco Annoni and Aldo Fumagalli Romario. SOL S.p.A. plays a vital role in supporting diverse industries and healthcare needs across Europe and beyond through innovation and sustainability-focused operations.